HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 20-MAR-15 4YVP TITLE CRYSTAL STRUCTURE OF AKR1C1 COMPLEXED WITH GLIBENCLAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE,20-ALPHA-HSD, COMPND 5 CHLORDECONE REDUCTASE HOMOLOG HAKRC,DIHYDRODIOL DEHYDROGENASE 1/2, COMPND 6 DD1/DD2,HIGH-AFFINITY HEPATIC BILE ACID-BINDING PROTEIN,HBAB,INDANOL COMPND 7 DEHYDROGENASE,TRANS-1,2-DIHYDROBENZENE-1,2-DIOL DEHYDROGENASE; COMPND 8 EC: 1.1.1.-,1.1.1.149,1.1.1.112,1.3.1.20; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1C1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(CONDON PLUS); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS AKR1C1 INHIBITOR, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.ZHAO,X.ZHENG,H.ZHANG,X.HU REVDAT 3 08-NOV-23 4YVP 1 REMARK HETSYN REVDAT 2 06-APR-16 4YVP 1 HETSYN REVDAT 1 25-NOV-15 4YVP 0 JRNL AUTH Y.ZHAO,X.ZHENG,H.ZHANG,J.ZHAI,L.ZHANG,C.LI,K.ZENG,Y.CHEN, JRNL AUTH 2 Q.LI,X.HU JRNL TITL IN VITRO INHIBITION OF AKR1CS BY SULPHONYLUREAS AND THE JRNL TITL 2 STRUCTURAL BASIS JRNL REF CHEM.BIOL.INTERACT. V. 240 310 2015 JRNL REFN ISSN 0009-2797 JRNL PMID 26362498 JRNL DOI 10.1016/J.CBI.2015.09.006 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0123 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 88.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 19305 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1375 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3160 REMARK 3 BIN FREE R VALUE SET COUNT : 77 REMARK 3 BIN FREE R VALUE : 0.3860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5092 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 162 REMARK 3 SOLVENT ATOMS : 136 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.04000 REMARK 3 B22 (A**2) : -0.80000 REMARK 3 B33 (A**2) : 1.92000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.66000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.346 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.305 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.834 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5382 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 5154 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7312 ; 1.571 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11880 ; 1.000 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 634 ; 6.630 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 244 ;36.116 ;24.180 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 922 ;13.958 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;15.468 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 796 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6138 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1226 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2542 ; 1.069 ; 1.868 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2541 ; 1.069 ; 1.868 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3174 ; 1.853 ; 2.800 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3175 ; 1.853 ; 2.801 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2840 ; 1.118 ; 1.931 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2841 ; 1.118 ; 1.932 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4139 ; 1.944 ; 2.837 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6230 ; 3.601 ;14.561 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6206 ; 3.569 ;14.566 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4YVP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000208035. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : SEALED TUBE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : OXFORD DIFFRACTION ENHANCE ULTRA REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MULTILAYER OPTICS REMARK 200 OPTICS : OXFORD ONYX CCD REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : OXFORD ONYX CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.21 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19305 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 88.385 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.66700 REMARK 200 R SYM FOR SHELL (I) : 0.66700 REMARK 200 FOR SHELL : 0.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3NTY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 23-27% (W/V) PEG 4000, 100 MM HEPES, REMARK 280 10MM CACL2, 0.4M NACL, PH 7.3, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.08400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 SER A 3 REMARK 465 LYS A 4 REMARK 465 TYR A 5 REMARK 465 MET B 1 REMARK 465 ASP B 2 REMARK 465 SER B 3 REMARK 465 LYS B 4 REMARK 465 TYR B 5 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 134 CG OD1 ND2 REMARK 470 ASN B 134 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 96 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 54 -38.01 -39.99 REMARK 500 ASN A 134 -73.96 -66.17 REMARK 500 PHE A 197 76.14 -151.31 REMARK 500 SER A 221 153.17 86.71 REMARK 500 ARG A 250 -164.03 -123.43 REMARK 500 ASN A 302 55.26 34.51 REMARK 500 SER B 221 158.54 87.00 REMARK 500 ARG B 223 13.57 54.70 REMARK 500 ARG B 250 -161.49 -120.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GBM A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GBM B 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4YVV RELATED DB: PDB REMARK 900 RELATED ID: 4YVX RELATED DB: PDB DBREF 4YVP A 1 323 UNP Q04828 AK1C1_HUMAN 1 323 DBREF 4YVP B 1 323 UNP Q04828 AK1C1_HUMAN 1 323 SEQRES 1 A 323 MET ASP SER LYS TYR GLN CYS VAL LYS LEU ASN ASP GLY SEQRES 2 A 323 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO SEQRES 3 A 323 ALA GLU VAL PRO LYS SER LYS ALA LEU GLU ALA THR LYS SEQRES 4 A 323 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA SEQRES 5 A 323 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE SEQRES 6 A 323 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP SEQRES 7 A 323 ILE PHE TYR THR SER LYS LEU TRP CYS ASN SER HIS ARG SEQRES 8 A 323 PRO GLU LEU VAL ARG PRO ALA LEU GLU ARG SER LEU LYS SEQRES 9 A 323 ASN LEU GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS SEQRES 10 A 323 PHE PRO VAL SER VAL LYS PRO GLY GLU GLU VAL ILE PRO SEQRES 11 A 323 LYS ASP GLU ASN GLY LYS ILE LEU PHE ASP THR VAL ASP SEQRES 12 A 323 LEU CYS ALA THR TRP GLU ALA VAL GLU LYS CYS LYS ASP SEQRES 13 A 323 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN SEQRES 14 A 323 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU SEQRES 15 A 323 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO SEQRES 16 A 323 TYR PHE ASN GLN ARG LYS LEU LEU ASP PHE CYS LYS SER SEQRES 17 A 323 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER SEQRES 18 A 323 HIS ARG GLU GLU PRO TRP VAL ASP PRO ASN SER PRO VAL SEQRES 19 A 323 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS SEQRES 20 A 323 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN SEQRES 21 A 323 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN SEQRES 22 A 323 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE SEQRES 23 A 323 GLN LEU THR SER GLU GLU MET LYS ALA ILE ASP GLY LEU SEQRES 24 A 323 ASN ARG ASN VAL ARG TYR LEU THR LEU ASP ILE PHE ALA SEQRES 25 A 323 GLY PRO PRO ASN TYR PRO PHE SER ASP GLU TYR SEQRES 1 B 323 MET ASP SER LYS TYR GLN CYS VAL LYS LEU ASN ASP GLY SEQRES 2 B 323 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO SEQRES 3 B 323 ALA GLU VAL PRO LYS SER LYS ALA LEU GLU ALA THR LYS SEQRES 4 B 323 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA SEQRES 5 B 323 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE SEQRES 6 B 323 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP SEQRES 7 B 323 ILE PHE TYR THR SER LYS LEU TRP CYS ASN SER HIS ARG SEQRES 8 B 323 PRO GLU LEU VAL ARG PRO ALA LEU GLU ARG SER LEU LYS SEQRES 9 B 323 ASN LEU GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS SEQRES 10 B 323 PHE PRO VAL SER VAL LYS PRO GLY GLU GLU VAL ILE PRO SEQRES 11 B 323 LYS ASP GLU ASN GLY LYS ILE LEU PHE ASP THR VAL ASP SEQRES 12 B 323 LEU CYS ALA THR TRP GLU ALA VAL GLU LYS CYS LYS ASP SEQRES 13 B 323 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN SEQRES 14 B 323 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU SEQRES 15 B 323 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO SEQRES 16 B 323 TYR PHE ASN GLN ARG LYS LEU LEU ASP PHE CYS LYS SER SEQRES 17 B 323 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER SEQRES 18 B 323 HIS ARG GLU GLU PRO TRP VAL ASP PRO ASN SER PRO VAL SEQRES 19 B 323 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS SEQRES 20 B 323 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN SEQRES 21 B 323 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN SEQRES 22 B 323 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE SEQRES 23 B 323 GLN LEU THR SER GLU GLU MET LYS ALA ILE ASP GLY LEU SEQRES 24 B 323 ASN ARG ASN VAL ARG TYR LEU THR LEU ASP ILE PHE ALA SEQRES 25 B 323 GLY PRO PRO ASN TYR PRO PHE SER ASP GLU TYR HET NAP A 401 48 HET GBM A 402 33 HET NAP B 401 48 HET GBM B 402 33 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM GBM 5-CHLORO-N-(2-{4-[(CYCLOHEXYLCARBAMOYL) HETNAM 2 GBM SULFAMOYL]PHENYL}ETHYL)-2-METHOXYBENZAMIDE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN GBM GLIBENCLAMIDE; GLYBURIDE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 GBM 2(C23 H28 CL N3 O5 S) FORMUL 7 HOH *136(H2 O) HELIX 1 AA1 LYS A 31 GLY A 45 1 15 HELIX 2 AA2 ASN A 57 ASP A 71 1 15 HELIX 3 AA3 LYS A 75 ILE A 79 5 5 HELIX 4 AA4 TRP A 86 HIS A 90 5 5 HELIX 5 AA5 ARG A 91 GLN A 107 1 17 HELIX 6 AA6 ASP A 143 ALA A 157 1 15 HELIX 7 AA7 ASN A 169 ASN A 178 1 10 HELIX 8 AA8 GLN A 199 LYS A 209 1 11 HELIX 9 AA9 VAL A 234 GLU A 237 5 4 HELIX 10 AB1 ASP A 238 LYS A 249 1 12 HELIX 11 AB2 THR A 251 ARG A 263 1 13 HELIX 12 AB3 ASN A 273 VAL A 281 1 9 HELIX 13 AB4 GLN A 282 PHE A 286 5 5 HELIX 14 AB5 THR A 289 GLY A 298 1 10 HELIX 15 AB6 LEU A 308 ALA A 312 5 5 HELIX 16 AB7 LYS B 31 GLY B 45 1 15 HELIX 17 AB8 ASN B 57 ASP B 71 1 15 HELIX 18 AB9 LYS B 75 ILE B 79 5 5 HELIX 19 AC1 TRP B 86 HIS B 90 5 5 HELIX 20 AC2 ARG B 91 GLU B 93 5 3 HELIX 21 AC3 LEU B 94 GLN B 107 1 14 HELIX 22 AC4 ASP B 143 ALA B 157 1 15 HELIX 23 AC5 ASN B 169 ASN B 178 1 10 HELIX 24 AC6 GLN B 199 LYS B 209 1 11 HELIX 25 AC7 VAL B 234 GLU B 237 5 4 HELIX 26 AC8 ASP B 238 LYS B 249 1 12 HELIX 27 AC9 THR B 251 GLN B 262 1 12 HELIX 28 AD1 ASN B 273 GLN B 282 1 10 HELIX 29 AD2 VAL B 283 PHE B 286 5 4 HELIX 30 AD3 THR B 289 GLY B 298 1 10 HELIX 31 AD4 LEU B 308 ALA B 312 5 5 SHEET 1 AA1 2 CYS A 7 LYS A 9 0 SHEET 2 AA1 2 PHE A 15 PRO A 17 -1 O MET A 16 N VAL A 8 SHEET 1 AA2 9 LEU A 19 GLY A 22 0 SHEET 2 AA2 9 HIS A 48 ASP A 50 1 O HIS A 48 N PHE A 21 SHEET 3 AA2 9 PHE A 80 LEU A 85 1 O PHE A 80 N ILE A 49 SHEET 4 AA2 9 VAL A 111 ILE A 116 1 O LEU A 115 N LEU A 85 SHEET 5 AA2 9 ALA A 160 SER A 166 1 O LYS A 161 N VAL A 111 SHEET 6 AA2 9 CYS A 188 GLU A 192 1 O CYS A 188 N VAL A 165 SHEET 7 AA2 9 VAL A 212 TYR A 216 1 O TYR A 216 N VAL A 191 SHEET 8 AA2 9 VAL A 266 LYS A 270 1 O LEU A 268 N ALA A 215 SHEET 9 AA2 9 LEU A 19 GLY A 22 1 N GLY A 22 O ALA A 269 SHEET 1 AA3 2 CYS B 7 LYS B 9 0 SHEET 2 AA3 2 PHE B 15 PRO B 17 -1 O MET B 16 N VAL B 8 SHEET 1 AA4 9 LEU B 19 GLY B 22 0 SHEET 2 AA4 9 HIS B 48 ASP B 50 1 O HIS B 48 N PHE B 21 SHEET 3 AA4 9 PHE B 80 LEU B 85 1 O THR B 82 N ILE B 49 SHEET 4 AA4 9 VAL B 111 ILE B 116 1 O LEU B 115 N LEU B 85 SHEET 5 AA4 9 ALA B 160 SER B 166 1 O LYS B 161 N VAL B 111 SHEET 6 AA4 9 CYS B 188 GLU B 192 1 O GLN B 190 N VAL B 165 SHEET 7 AA4 9 VAL B 212 TYR B 216 1 O VAL B 212 N ASN B 189 SHEET 8 AA4 9 VAL B 266 LYS B 270 1 O VAL B 266 N ALA B 215 SHEET 9 AA4 9 LEU B 19 GLY B 22 1 N GLY B 20 O VAL B 267 CISPEP 1 GLU A 225 PRO A 226 0 2.70 CISPEP 2 GLU B 225 PRO B 226 0 6.34 SITE 1 AC1 28 GLY A 22 THR A 23 TYR A 24 ASP A 50 SITE 2 AC1 28 TYR A 55 LYS A 84 SER A 166 ASN A 167 SITE 3 AC1 28 GLN A 190 TYR A 216 SER A 217 ALA A 218 SITE 4 AC1 28 LEU A 219 GLY A 220 SER A 221 HIS A 222 SITE 5 AC1 28 LEU A 236 ALA A 253 LYS A 270 SER A 271 SITE 6 AC1 28 TYR A 272 ASN A 273 ARG A 276 GLN A 279 SITE 7 AC1 28 ASN A 280 LEU A 306 GBM A 402 HOH A 521 SITE 1 AC2 9 TYR A 24 LEU A 54 TYR A 55 HIS A 117 SITE 2 AC2 9 ILE A 129 HIS A 222 TRP A 227 LEU A 306 SITE 3 AC2 9 NAP A 401 SITE 1 AC3 32 GLY B 22 THR B 23 TYR B 24 ASP B 50 SITE 2 AC3 32 TYR B 55 SER B 166 ASN B 167 GLN B 190 SITE 3 AC3 32 TYR B 216 SER B 217 ALA B 218 LEU B 219 SITE 4 AC3 32 GLY B 220 SER B 221 HIS B 222 LEU B 236 SITE 5 AC3 32 ALA B 253 LEU B 268 LYS B 270 SER B 271 SITE 6 AC3 32 TYR B 272 ARG B 276 GLN B 279 ASN B 280 SITE 7 AC3 32 LEU B 306 GBM B 402 HOH B 529 HOH B 530 SITE 8 AC3 32 HOH B 539 HOH B 540 HOH B 549 HOH B 554 SITE 1 AC4 11 TYR B 24 LEU B 54 TYR B 55 TRP B 86 SITE 2 AC4 11 HIS B 117 VAL B 128 HIS B 222 TRP B 227 SITE 3 AC4 11 LEU B 306 LEU B 308 NAP B 401 CRYST1 49.545 76.168 88.706 90.00 94.88 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020184 0.000000 0.001723 0.00000 SCALE2 0.000000 0.013129 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011314 0.00000